Diabetes Complications

"Diabetes Complications" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.

Descriptor ID	D048909
MeSH Number(s)	C19.246.099
Concept/Terms	Diabetes Complications Diabetes Complications Diabetes Complication Diabetes-Related Complications Diabetes Related Complications Diabetes-Related Complication Diabetic Complications Diabetic Complication Complications of Diabetes Mellitus Diabetes Mellitus Complication Diabetes Mellitus Complications

Below are MeSH descriptors whose meaning is more general than "Diabetes Complications".

Diseases [C]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]

Below are MeSH descriptors whose meaning is related to "Diabetes Complications".

Below are MeSH descriptors whose meaning is more specific than "Diabetes Complications".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetes Complications" by people in this website by year, and whether "Diabetes Complications" was a major or minor topic of these publications.

Bar chart showing 136 publications over 25 distinct years, with a maximum of 10 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1995	1	1	2
1998	2	1	3
1999	1	0	1
2001	1	2	3
2002	5	4	9
2003	2	4	6
2004	2	4	6
2005	1	7	8
2006	4	2	6
2007	4	2	6
2008	4	3	7
2009	5	4	9
2010	5	5	10
2011	4	2	6
2012	2	3	5
2013	5	3	8
2014	4	5	9
2015	3	2	5
2016	5	3	8
2017	1	0	1
2018	4	2	6
2019	2	0	2
2020	6	1	7
2021	2	0	2

Below are the most recent publications written about "Diabetes Complications" by people in Profiles.

Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci. 2021 Nov 15; 22(22).

View in: PubMed
Manduteanu I, Simionescu D, Simionescu A, Simionescu M. Aortic valve disease in diabetes: Molecular mechanisms and novel therapies. J Cell Mol Med. 2021 10; 25(20):9483-9495.

View in: PubMed
Cheng F, Carroll L, Joglekar MV, Januszewski AS, Wong KK, Hardikar AA, Jenkins AJ, Ma RCW. Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021 02; 9(2):117-126.

View in: PubMed
Contreras G, Lu L, Tamariz L, Rocco MV, Papademetriou V, Kostis JB, Pisoni R, Glasser SP, Sweeney ME, Basile J, Gren LH, Zamanian S, Cushman WC. Outcomes in adults with systolic blood pressure between 130 and 139?mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial. J Hypertens. 2020 08; 38(8):1567-1577.

View in: PubMed
Aljehani FA, Funke K, Hermayer KL. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era. Am J Med Sci. 2020 10; 360(4):423-426.

View in: PubMed
Vujkovic M, Keaton JM, Lynch JA, Miller DR, Zhou J, Tcheandjieu C, Huffman JE, Assimes TL, Lorenz K, Zhu X, Hilliard AT, Judy RL, Huang J, Lee KM, Klarin D, Pyarajan S, Danesh J, Melander O, Rasheed A, Mallick NH, Hameed S, Qureshi IH, Afzal MN, Malik U, Jalal A, Abbas S, Sheng X, Gao L, Kaestner KH, Susztak K, Sun YV, DuVall SL, Cho K, Lee JS, Gaziano JM, Phillips LS, Meigs JB, Reaven PD, Wilson PW, Edwards TL, Rader DJ, Damrauer SM, O'Donnell CJ, Tsao PS, Chang KM, Voight BF, Saleheen D. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020 07; 52(7):680-691.

View in: PubMed
Stoian AP, Banerjee Y, Rizvi AA, Rizzo M. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175.

View in: PubMed
Abdul Y, Jamil S, He L, Li W, Ergul A. Endothelin-1 (ET-1) promotes a proinflammatory microglia phenotype in diabetic conditions. Can J Physiol Pharmacol. 2020 Sep; 98(9):596-603.

View in: PubMed
Pothoulakis I, Paragomi P, Archibugi L, Tuft M, Talukdar R, Kochhar R, Goenka MK, Gulla A, Singh VK, Gonzalez JA, Ferreira M, Barbu ST, Stevens T, Nawaz H, Gutierrez SC, Zarnescu NO, Easler J, Triantafyllou K, Pelaez-Luna M, Thakkar S, Ocampo C, de-Madaria E, Wu BU, Cote GA, Tang G, Papachristou GI, Capurso G. Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium). Pancreatology. 2020 Apr; 20(3):325-330.

View in: PubMed
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019 08; 7(8):618-628.

View in: PubMed

People

Explore

Similar Concepts

Top Journals